Filing Details
- Accession Number:
- 0001055726-20-000056
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-17 19:07:19
- Reporting Period:
- 2020-12-15
- Accepted Time:
- 2020-12-17 19:07:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1055726 | Inovio Pharmaceuticals Inc. | INO | Surgical & Medical Instruments & Apparatus (3841) | 330969592 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1259780 | Peter Kies | C/O Inovio Pharmaceuticals, Inc. 6769 Mesa Ridge Road San Diego CA 92121 | Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-15 | 8,750 | $2.40 | 128,040 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-12-15 | 11,250 | $2.16 | 139,290 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-15 | 20,000 | $10.69 | 119,290 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Option | Disposition | 2020-12-15 | 8,750 | $0.00 | 8,750 | $2.40 |
| Common Stock | Common Stock Option | Disposition | 2020-12-15 | 11,250 | $0.00 | 11,250 | $2.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2012-02-23 | 2022-02-23 | No | 4 | M | Direct |
| 33,750 | 2013-03-14 | 2023-03-14 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,500 | Indirect | By Spouse |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- These transactions were executed in multiple trades at prices ranging from $10.52 to $10.83, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014.
Billionaire Hedge Funds
